Global Hepatitis A Vaccine Market Analysis and Forecast 2024-2030
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, The global Hepatitis A Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
This report presents an overview of global market for Hepatitis A Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hepatitis A Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis A Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hepatitis A Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hepatitis A Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hepatitis A Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCA and ChangSheng, etc.
Hepatitis A Vaccine segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Hepatitis A Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
According to APO Research, The global Hepatitis A Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Hepatitis A Vaccine key players include GSK, Merck, Sanofi, etc. Global top three manufacturers hold a share over 85%.
Europe is the largest market, with a share over 30%, followed by North America and China, both have a share about 45 percent.
In terms of product, Inactivated Vaccine is the largest segment, with a share about 70%. And in terms of application, the largest application is Government Institution, followed by Private Sector, etc.
This report presents an overview of global market for Hepatitis A Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hepatitis A Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis A Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hepatitis A Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hepatitis A Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hepatitis A Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCA and ChangSheng, etc.
Hepatitis A Vaccine segment by Company
- GSK
- Merck
- Sanofi
- Sinovac
- Zhejiang Pukang
- Changchun Institute of Biological
- KM Biologics
- IMBCA
- ChangSheng
- Convac
- Inactivated Vaccine
- Live Attenuated Vaccine
- Government Institution
- Private Sector
- Other
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis A Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis A Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis A Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Hepatitis A Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hepatitis A Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis A Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Hepatitis A Vaccine Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HEPATITIS A VACCINE MARKET DYNAMICS
2.1 Hepatitis A Vaccine Industry Trends
2.2 Hepatitis A Vaccine Industry Drivers
2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
2.4 Hepatitis A Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Hepatitis A Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Hepatitis A Vaccine Revenue by Region
3.2.1 Global Hepatitis A Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Hepatitis A Vaccine Revenue by Region (2019-2024)
3.2.3 Global Hepatitis A Vaccine Revenue by Region (2025-2030)
3.2.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Hepatitis A Vaccine Sales by Region
3.4.1 Global Hepatitis A Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Hepatitis A Vaccine Sales by Region (2019-2024)
3.4.3 Global Hepatitis A Vaccine Sales by Region (2025-2030)
3.4.4 Global Hepatitis A Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Hepatitis A Vaccine Revenue by Manufacturers
4.1.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Hepatitis A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Hepatitis A Vaccine Sales by Manufacturers
4.2.1 Global Hepatitis A Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Hepatitis A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Hepatitis A Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Hepatitis A Vaccine Manufacturers, Product Type & Application
4.7 Global Hepatitis A Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
4.8.2 2023 Hepatitis A Vaccine Tier 1, Tier 2, and Tier
5 HEPATITIS A VACCINE MARKET BY TYPE
5.1 Global Hepatitis A Vaccine Revenue by Type
5.1.1 Global Hepatitis A Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Hepatitis A Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Hepatitis A Vaccine Sales by Type
5.2.1 Global Hepatitis A Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (K Unit)
5.2.3 Global Hepatitis A Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Hepatitis A Vaccine Price by Type
6 HEPATITIS A VACCINE MARKET BY APPLICATION
6.1 Global Hepatitis A Vaccine Revenue by Application
6.1.1 Global Hepatitis A Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Hepatitis A Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Hepatitis A Vaccine Sales by Application
6.2.1 Global Hepatitis A Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (K Unit)
6.2.3 Global Hepatitis A Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Hepatitis A Vaccine Price by Application
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Hepatitis A Vaccine Product Portfolio
7.1.5 GSK Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merck Hepatitis A Vaccine Product Portfolio
7.2.5 Merck Recent Developments
7.3 Sanofi
7.3.1 Sanofi Comapny Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
7.3.5 Sanofi Recent Developments
7.4 Sinovac
7.4.1 Sinovac Comapny Information
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
7.4.5 Sinovac Recent Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Comapny Information
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
7.5.5 Zhejiang Pukang Recent Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Comapny Information
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
7.6.5 Changchun Institute of Biological Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 IMBCA
7.8.1 IMBCA Comapny Information
7.8.2 IMBCA Business Overview
7.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
7.8.5 IMBCA Recent Developments
7.9 ChangSheng
7.9.1 ChangSheng Comapny Information
7.9.2 ChangSheng Business Overview
7.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
7.9.5 ChangSheng Recent Developments
7.10 Convac
7.10.1 Convac Comapny Information
7.10.2 Convac Business Overview
7.10.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Convac Hepatitis A Vaccine Product Portfolio
7.10.5 Convac Recent Developments
8 NORTH AMERICA
8.1 North America Hepatitis A Vaccine Market Size by Type
8.1.1 North America Hepatitis A Vaccine Revenue by Type (2019-2030)
8.1.2 North America Hepatitis A Vaccine Sales by Type (2019-2030)
8.1.3 North America Hepatitis A Vaccine Price by Type (2019-2030)
8.2 North America Hepatitis A Vaccine Market Size by Application
8.2.1 North America Hepatitis A Vaccine Revenue by Application (2019-2030)
8.2.2 North America Hepatitis A Vaccine Sales by Application (2019-2030)
8.2.3 North America Hepatitis A Vaccine Price by Application (2019-2030)
8.3 North America Hepatitis A Vaccine Market Size by Country
8.3.1 North America Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Hepatitis A Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Hepatitis A Vaccine Market Size by Type
9.1.1 Europe Hepatitis A Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Hepatitis A Vaccine Sales by Type (2019-2030)
9.1.3 Europe Hepatitis A Vaccine Price by Type (2019-2030)
9.2 Europe Hepatitis A Vaccine Market Size by Application
9.2.1 Europe Hepatitis A Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Hepatitis A Vaccine Sales by Application (2019-2030)
9.2.3 Europe Hepatitis A Vaccine Price by Application (2019-2030)
9.3 Europe Hepatitis A Vaccine Market Size by Country
9.3.1 Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Hepatitis A Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Hepatitis A Vaccine Market Size by Type
10.1.1 China Hepatitis A Vaccine Revenue by Type (2019-2030)
10.1.2 China Hepatitis A Vaccine Sales by Type (2019-2030)
10.1.3 China Hepatitis A Vaccine Price by Type (2019-2030)
10.2 China Hepatitis A Vaccine Market Size by Application
10.2.1 China Hepatitis A Vaccine Revenue by Application (2019-2030)
10.2.2 China Hepatitis A Vaccine Sales by Application (2019-2030)
10.2.3 China Hepatitis A Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Hepatitis A Vaccine Market Size by Type
11.1.1 Asia Hepatitis A Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Hepatitis A Vaccine Sales by Type (2019-2030)
11.1.3 Asia Hepatitis A Vaccine Price by Type (2019-2030)
11.2 Asia Hepatitis A Vaccine Market Size by Application
11.2.1 Asia Hepatitis A Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Hepatitis A Vaccine Sales by Application (2019-2030)
11.2.3 Asia Hepatitis A Vaccine Price by Application (2019-2030)
11.3 Asia Hepatitis A Vaccine Market Size by Country
11.3.1 Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Hepatitis A Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Hepatitis A Vaccine Market Size by Type
12.1.1 MEALA Hepatitis A Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Hepatitis A Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Hepatitis A Vaccine Price by Type (2019-2030)
12.2 MEALA Hepatitis A Vaccine Market Size by Application
12.2.1 MEALA Hepatitis A Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Hepatitis A Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Hepatitis A Vaccine Price by Application (2019-2030)
12.3 MEALA Hepatitis A Vaccine Market Size by Country
12.3.1 MEALA Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Hepatitis A Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Hepatitis A Vaccine Value Chain Analysis
13.1.1 Hepatitis A Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Hepatitis A Vaccine Production Mode & Process
13.2 Hepatitis A Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Hepatitis A Vaccine Distributors
13.2.3 Hepatitis A Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Hepatitis A Vaccine Market by Type
1.2.1 Global Hepatitis A Vaccine Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Hepatitis A Vaccine Market by Application
1.3.1 Global Hepatitis A Vaccine Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 HEPATITIS A VACCINE MARKET DYNAMICS
2.1 Hepatitis A Vaccine Industry Trends
2.2 Hepatitis A Vaccine Industry Drivers
2.3 Hepatitis A Vaccine Industry Opportunities and Challenges
2.4 Hepatitis A Vaccine Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Hepatitis A Vaccine Revenue Estimates and Forecasts (2019-2030)
3.2 Global Hepatitis A Vaccine Revenue by Region
3.2.1 Global Hepatitis A Vaccine Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Hepatitis A Vaccine Revenue by Region (2019-2024)
3.2.3 Global Hepatitis A Vaccine Revenue by Region (2025-2030)
3.2.4 Global Hepatitis A Vaccine Revenue Market Share by Region (2019-2030)
3.3 Global Hepatitis A Vaccine Sales Estimates and Forecasts 2019-2030
3.4 Global Hepatitis A Vaccine Sales by Region
3.4.1 Global Hepatitis A Vaccine Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Hepatitis A Vaccine Sales by Region (2019-2024)
3.4.3 Global Hepatitis A Vaccine Sales by Region (2025-2030)
3.4.4 Global Hepatitis A Vaccine Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Hepatitis A Vaccine Revenue by Manufacturers
4.1.1 Global Hepatitis A Vaccine Revenue by Manufacturers (2019-2024)
4.1.2 Global Hepatitis A Vaccine Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Hepatitis A Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Hepatitis A Vaccine Sales by Manufacturers
4.2.1 Global Hepatitis A Vaccine Sales by Manufacturers (2019-2024)
4.2.2 Global Hepatitis A Vaccine Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Hepatitis A Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Hepatitis A Vaccine Sales Price by Manufacturers (2019-2024)
4.4 Global Hepatitis A Vaccine Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Hepatitis A Vaccine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Hepatitis A Vaccine Manufacturers, Product Type & Application
4.7 Global Hepatitis A Vaccine Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Hepatitis A Vaccine Market CR5 and HHI
4.8.2 2023 Hepatitis A Vaccine Tier 1, Tier 2, and Tier
5 HEPATITIS A VACCINE MARKET BY TYPE
5.1 Global Hepatitis A Vaccine Revenue by Type
5.1.1 Global Hepatitis A Vaccine Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Hepatitis A Vaccine Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Hepatitis A Vaccine Revenue Market Share by Type (2019-2030)
5.2 Global Hepatitis A Vaccine Sales by Type
5.2.1 Global Hepatitis A Vaccine Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Hepatitis A Vaccine Sales by Type (2019-2030) & (K Unit)
5.2.3 Global Hepatitis A Vaccine Sales Market Share by Type (2019-2030)
5.3 Global Hepatitis A Vaccine Price by Type
6 HEPATITIS A VACCINE MARKET BY APPLICATION
6.1 Global Hepatitis A Vaccine Revenue by Application
6.1.1 Global Hepatitis A Vaccine Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Hepatitis A Vaccine Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Hepatitis A Vaccine Revenue Market Share by Application (2019-2030)
6.2 Global Hepatitis A Vaccine Sales by Application
6.2.1 Global Hepatitis A Vaccine Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Hepatitis A Vaccine Sales by Application (2019-2030) & (K Unit)
6.2.3 Global Hepatitis A Vaccine Sales Market Share by Application (2019-2030)
6.3 Global Hepatitis A Vaccine Price by Application
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Hepatitis A Vaccine Product Portfolio
7.1.5 GSK Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merck Hepatitis A Vaccine Product Portfolio
7.2.5 Merck Recent Developments
7.3 Sanofi
7.3.1 Sanofi Comapny Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Sanofi Hepatitis A Vaccine Product Portfolio
7.3.5 Sanofi Recent Developments
7.4 Sinovac
7.4.1 Sinovac Comapny Information
7.4.2 Sinovac Business Overview
7.4.3 Sinovac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Sinovac Hepatitis A Vaccine Product Portfolio
7.4.5 Sinovac Recent Developments
7.5 Zhejiang Pukang
7.5.1 Zhejiang Pukang Comapny Information
7.5.2 Zhejiang Pukang Business Overview
7.5.3 Zhejiang Pukang Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Zhejiang Pukang Hepatitis A Vaccine Product Portfolio
7.5.5 Zhejiang Pukang Recent Developments
7.6 Changchun Institute of Biological
7.6.1 Changchun Institute of Biological Comapny Information
7.6.2 Changchun Institute of Biological Business Overview
7.6.3 Changchun Institute of Biological Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Changchun Institute of Biological Hepatitis A Vaccine Product Portfolio
7.6.5 Changchun Institute of Biological Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Hepatitis A Vaccine Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 IMBCA
7.8.1 IMBCA Comapny Information
7.8.2 IMBCA Business Overview
7.8.3 IMBCA Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 IMBCA Hepatitis A Vaccine Product Portfolio
7.8.5 IMBCA Recent Developments
7.9 ChangSheng
7.9.1 ChangSheng Comapny Information
7.9.2 ChangSheng Business Overview
7.9.3 ChangSheng Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 ChangSheng Hepatitis A Vaccine Product Portfolio
7.9.5 ChangSheng Recent Developments
7.10 Convac
7.10.1 Convac Comapny Information
7.10.2 Convac Business Overview
7.10.3 Convac Hepatitis A Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Convac Hepatitis A Vaccine Product Portfolio
7.10.5 Convac Recent Developments
8 NORTH AMERICA
8.1 North America Hepatitis A Vaccine Market Size by Type
8.1.1 North America Hepatitis A Vaccine Revenue by Type (2019-2030)
8.1.2 North America Hepatitis A Vaccine Sales by Type (2019-2030)
8.1.3 North America Hepatitis A Vaccine Price by Type (2019-2030)
8.2 North America Hepatitis A Vaccine Market Size by Application
8.2.1 North America Hepatitis A Vaccine Revenue by Application (2019-2030)
8.2.2 North America Hepatitis A Vaccine Sales by Application (2019-2030)
8.2.3 North America Hepatitis A Vaccine Price by Application (2019-2030)
8.3 North America Hepatitis A Vaccine Market Size by Country
8.3.1 North America Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Hepatitis A Vaccine Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Hepatitis A Vaccine Market Size by Type
9.1.1 Europe Hepatitis A Vaccine Revenue by Type (2019-2030)
9.1.2 Europe Hepatitis A Vaccine Sales by Type (2019-2030)
9.1.3 Europe Hepatitis A Vaccine Price by Type (2019-2030)
9.2 Europe Hepatitis A Vaccine Market Size by Application
9.2.1 Europe Hepatitis A Vaccine Revenue by Application (2019-2030)
9.2.2 Europe Hepatitis A Vaccine Sales by Application (2019-2030)
9.2.3 Europe Hepatitis A Vaccine Price by Application (2019-2030)
9.3 Europe Hepatitis A Vaccine Market Size by Country
9.3.1 Europe Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Hepatitis A Vaccine Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Hepatitis A Vaccine Market Size by Type
10.1.1 China Hepatitis A Vaccine Revenue by Type (2019-2030)
10.1.2 China Hepatitis A Vaccine Sales by Type (2019-2030)
10.1.3 China Hepatitis A Vaccine Price by Type (2019-2030)
10.2 China Hepatitis A Vaccine Market Size by Application
10.2.1 China Hepatitis A Vaccine Revenue by Application (2019-2030)
10.2.2 China Hepatitis A Vaccine Sales by Application (2019-2030)
10.2.3 China Hepatitis A Vaccine Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Hepatitis A Vaccine Market Size by Type
11.1.1 Asia Hepatitis A Vaccine Revenue by Type (2019-2030)
11.1.2 Asia Hepatitis A Vaccine Sales by Type (2019-2030)
11.1.3 Asia Hepatitis A Vaccine Price by Type (2019-2030)
11.2 Asia Hepatitis A Vaccine Market Size by Application
11.2.1 Asia Hepatitis A Vaccine Revenue by Application (2019-2030)
11.2.2 Asia Hepatitis A Vaccine Sales by Application (2019-2030)
11.2.3 Asia Hepatitis A Vaccine Price by Application (2019-2030)
11.3 Asia Hepatitis A Vaccine Market Size by Country
11.3.1 Asia Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Hepatitis A Vaccine Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Hepatitis A Vaccine Market Size by Type
12.1.1 MEALA Hepatitis A Vaccine Revenue by Type (2019-2030)
12.1.2 MEALA Hepatitis A Vaccine Sales by Type (2019-2030)
12.1.3 MEALA Hepatitis A Vaccine Price by Type (2019-2030)
12.2 MEALA Hepatitis A Vaccine Market Size by Application
12.2.1 MEALA Hepatitis A Vaccine Revenue by Application (2019-2030)
12.2.2 MEALA Hepatitis A Vaccine Sales by Application (2019-2030)
12.2.3 MEALA Hepatitis A Vaccine Price by Application (2019-2030)
12.3 MEALA Hepatitis A Vaccine Market Size by Country
12.3.1 MEALA Hepatitis A Vaccine Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Hepatitis A Vaccine Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Hepatitis A Vaccine Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Hepatitis A Vaccine Value Chain Analysis
13.1.1 Hepatitis A Vaccine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Hepatitis A Vaccine Production Mode & Process
13.2 Hepatitis A Vaccine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Hepatitis A Vaccine Distributors
13.2.3 Hepatitis A Vaccine Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
